cefotiam has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishihara, Y; Kitamura, S; Takaku, F | 1 |
Nishi, T; Tsuchiya, K | 1 |
Asahi, Y; Goto, M; Inoue, M; Kaji, Y; Kimura, S; Matsuda, K; Nakagawa, S; Oka, S; Sanada, M; Shimada, K | 1 |
3 other study(ies) available for cefotiam and Disease Models, Animal
Article | Year |
---|---|
[Experimental studies on distribution of cefotiam, a new beta-lactam antibiotic, in the lung and trachea of rabbits. II. Combined effects with serratiopeptidase].
Topics: Animals; Cefotaxime; Cefotiam; Disease Models, Animal; Lung; Male; Peptide Hydrolases; Pleurisy; Pneumonia; Rabbits; Tissue Distribution; Trachea | 1983 |
Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
Topics: Animals; Cefazolin; Cefotiam; Cephalosporins; Disease Models, Animal; Drug Administration Schedule; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Pneumonia | 1980 |
Synergic activity of imipenem/cilastatin combined with cefotiam against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Cefotiam; Cilastatin; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Imipenem; Kinetics; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Staphylococcal Infections; Staphylococcus aureus | 1993 |